ICU Medical (Nasdaq: ICUI) announced today that it received FDA 510(k) clearance for several new additions to its infusion pump portfolio.

The infusion pumps market is experiencing significant growth due to the increasing demand for advanced healthcare solutions, particularly in the management of chronic diseases and critical care.

The Infusion Pump Market is valued at USD 14257.99 Million in 2022 and is expected to reach USD 27383.94 Million by 2030 at a ...

San Clemente, California Wednesday, April 9, 2025, 11:00 Hrs [IST] ...

IRadimed Corporation offers steady revenue growth with 14 consecutive quarters of record revenue and a small dividend, ...

The global infusion pump market was estimated to be worth ... by software failure modes while Smiths Medical issued a medical device correction for its software-affected infusion pumps in August ...

New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform. Unlike traditional pumps that rely on specific setups and conditions for accurate delivery ...

ICU Medical Inc. (NASDAQ:ICUI), a worldwide leader in the development, manufacture and sale of innovative medical devices, has announced 510(k) regulatory clearance from the U.S. Food and Drug ...